Concepedia

Ian Spendlove

IS

57

Publications

3.8K

Citations

34

H-Index

1992

Active since

Affiliations

University of Nottingham(Current)

Nottingham City Hospital

Queen's Medical Centre

Nottingham University Hospitals NHS Trust

Cancer Research UK

Ian Spendlove is an author at University of Nottingham specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

1992–2023

57

Publications

57

Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis

Guruprasad P. Aithal, James A. Thomas, Philip Kaye et al. · Gastroenterology · 2008 · 696 citations

, , +10

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis

Nicholas FS Watson, Judith M. Ramage, Zahra Madjd et al. · International Journal of Cancer · 2005 · 246 citations

αB crystallin expression in nonlenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease

James Lowe, Helen McDermott, Ian Pike et al. · The Journal of Pathology · 1992 · 211 citations

Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients

Nicholas FS Watson, Ian Spendlove, Zahra Madjd et al. · International Journal of Cancer · 2005 · 159 citations · Full text

Total loss of MHC class I is an independent indicator of good prognosis in breast cancer

Zahra Madjd, Ian Spendlove, Sarah E. Pinder et al. · International Journal of Cancer · 2005 · 146 citations · Full text

Rows per page

1–5 of 57